Evidence map›Paper›PMID 18650959›Full record

ArticleDrug discovery today. Disease models2007

The role of Na dysregulation in cardiac disease and how it impacts electrophysiology.

Brian O'Rourke, Christoph Maack

Open access · greenAbstract read
In one paragraph

Article in Drug discovery today. Disease models, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. NCLX: the mitochondrial sodium calcium exchanger.Journal of molecular and cellular cardiology · 2013
    Article
  10. Role of mitochondrial dysfunction in cardiac glycoside toxicity.Journal of molecular and cellular cardiology · 2010
    Article
  11. Mitochondria in cardiomyocyte Ca2+ signaling.The international journal of biochemistry & cell biology · 2009
    Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Brian O'RourkeThe Johns Hopkins University, Institute of Molecular Cardiobiology, Division of Cardiology, Baltimore, MD, USA.
Christoph Maack
Johns Hopkins University · USUniversitätsklinikum des Saarlandes · DE

Funding

STRUCTURE OF MITOCHONDRIAL K+ CHANNELSP01HL081427 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI O'ROURKE, BRIAN · 2005 to 2009
$11.2M
ENERGETIC REGULATION OF CARDIAC ION CHANNELSR37HL054598 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI O'ROURKE, BRIAN · 2005 to 2014
$3.7M
CROSS-MODULATION OF EXCITABILITY/CA IN HEART FAILURER01HL061711 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI O'ROURKE, BRIAN · 1999 to 2007
$2.1M
NHLBI NIH HHS P01 HL081427NHLBI NIH HHS R01 HL061711NHLBI NIH HHS R37 HL054598
6 · The paper itself

Abstract

Ca(2+) is well known as the central player in cardiac cell physiology, mediating Ca(2+) activation of myosin ATPase and contraction, the stimulation of Ca(2+)-activated signaling pathways and modulation of mitochondrial energy production. Abnormalities of Ca(2+) handling are a well-studied mechanism of decompensation in heart failure. Less appreciated is the role of cytosolic Na(+) (Na(i) (+)), which can dramatically influence the transfer rates and distribution of Ca(2+) among the intracellular compartments of the myocyte. Since Na(i) (+) can vary widely under different physiological and pathological conditions, and its effects depend on multiple ion gradients and membrane electrical potentials, unraveling the global influence of Na(i) (+) on cell function is complex, requiring an integrative view of cardiomyocyte physiology. Here, we discuss how abnormal Na(i) (+) regulation not only influences the cytosolic Ca(2+) transient and the cellular action potential but also alters mitochondrial Ca(2+) uptake and the balance of energy supply and demand of the cardiomyocyte, which may contribute to oxidative stress and cardiac decompensation. The implications for sudden cardiac death and the potential for novel therapeutic interventions are discussed.

Identifiers

PMID18650959
PMCPMC2440714
OpenAlexW2087289919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.